Oxycodone Hydrochloride Oral Solution recalled for missing label
Akorn, Inc. is recalling Oxycodone Hydrochloride Oral Solution 5 mg per 5 mL distributed nationwide due to missing label.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall involving a labeling defect (missing label). Class III recalls are typically scored 1 or 2; the moderate score reflects the safety-relevant nature of a missing label on a prescription opioid, which could lead to dosing or administration errors if the label information is not available to the dispensing pharmacist or patient.
Plain-English summary
Akorn, Inc. is recalling Oxycodone Hydrochloride Oral Solution, USP 5 mg per 5 mL (1 mg/mL), 500 mL bottles manufactured by Hi-Tech Pharmacal Co., Inc. The recall affects 8,184 bottles distributed nationwide in the United States.
The recall was initiated due to missing label on the affected product. The affected lots are Lot 377186 (Exp. 2/28/2023) and Lot 377188 (Exp. 3/31/2023), identified by NDC 50383-961-34.
Consumers and healthcare providers who have received this product should not use it and should contact Akorn, Inc. or their pharmacy for replacement product or instructions on proper disposition.
The recalled product
- Product
- Oxycodone Hydrochloride Oral Solution, USP 5 mg per 5 mL (1 mg/mL), 500 mL bottle, Rx only, Manufactured by: Hi-Tech Pharmacal Co., Inc., Amityville, NY 11701 --- NDC 50383-961-34
- Manufacturer
- Akorn, Inc.
- Hazard
- missing-label
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: 377186 Exp. 2/28/2023
- 377188 Exp. 3/31/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27